Excerpt re ARYC: "Tracing its roots back to the mid-1990’s this microarray pioneer is poised to garner a meaningful share of the large and growing microarray market. Industry research firm Research Moz projects that the microarray industry will enjoy an 18% CAGR and reach the $11.4 billion mark in 2018.
With 8 patent awards, Arrayit is one of the original innovators in the critical microarray field. ARYC’s proprietary platform includes a huge suite of tools and integrated systems used by biopharma firms, research centers, diagnostic firms and others for study and analysis of genetic variation and biomedical functions
Based on its IP alone, Arrayit is incredibly undervalued. ARYC has successfully defended its deep and foundational patent portfolio and similar industry patents have indicated a value of $90M or more in recent transactions."
Customers such as Novartis, countless research hospitals and universities, biotechs, governments and military branches, etc. and so on in my world makes ARYC a MAJOR player, and add to that their important patents. This is a small company with significant revenues reported daily, so I don't believe "huge" is an exaggeration at all.
News 
Market Data 
Discover 
